Category Archives: Obviousness

KSR Panel at AIPLA Annual Meeting

Posted on October 25, 2010 by Warren Woessner

Thanks to all of you who attended (or tried to attend) the panel presentations on KSR Tuesday morning at the AIPLA Annual Meeting. We apologize, but were pleasantly surprised, that the room was too small to accommodate all who wished … Continue reading →

Posted in Conferences and Classes, Obviousness | Tagged , , , | Leave a comment

USPTO Issues “2010 KSR Guidelines Update”

Posted on September 7, 2010 by Warren Woessner

On September 1st, the Office of Patent Legal Administration (I didn’t know there was one) issued 17 pages in the Fed. Reg. (Vol. 75, 53643) updating its obviousness guidelines. (A copy of the guidelines is found at the end of … Continue reading →

Posted in Obviousness | Tagged , , , , , , , , , , | 1 Comment

CANCELLATION OF WARF STEM CELL CLAIMS: THE “DR. HYDE” SIDE OF KSR

Posted on May 25, 2010 by Warren Woessner

Recently, in a notably unremarked decision, the Board reversed the Examiner, effectively canceling all of the claims to pluripotent human embryonic stem cells (ES) in Thomson (U.S. Pat. No. 7029913): The Foundation for Taxpayer & Consumer Rights v. Patent of Wisconsin Alumni … Continue reading →

Posted in Obviousness | Tagged , , , | Leave a comment

David Kappos and The Impact of KSR – A Unique Opportunity For Our Profession

Posted on December 7, 2009 by Warren Woessner

By Paul Cole Visiting Professor, Intellectual Property Law, Bournemouth University, UK On Tuesday 24 November, David Kappos made a posting on the Director’s Forum including the following statement: Some have suggested that the Office is determining obviousness in a way … Continue reading →

Posted in Obviousness | Tagged , , , , , | Leave a comment